We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
3651
Interactive Brokers
IBKR
$39.8B
-131,596
Closed -$2.12M
IBND icon
3652
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
-6,662
Closed -$225K
IDCC icon
3653
InterDigital
IDCC
$8.89B
-2,592
Closed -$210K
IIF
3654
Morgan Stanley India Investment Fund
IIF
$220M
-10,381
Closed -$269K
IOVA icon
3655
Iovance Biotherapeutics
IOVA
$2.87B
-52,856
Closed -$677K
ITGR icon
3656
Integer Holdings
ITGR
$4.26B
-17,773
Closed -$1.15M
JEQ
3657
DELISTED
abrdn Japan Equity Fund
JEQ
-14,413
Closed -$127K
KBE icon
3658
CALL
State Street SPDR S&P Bank ETF
KBE
$1.71B
-15,200
Closed -$2K
KMB icon
3659
CALL
Kimberly-Clark
KMB
$36.5B
-59,600
Closed -$155K
LEMB icon
3660
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$724M
-7,845
Closed -$348K
MGRC icon
3661
McGrath RentCorp
MGRC
$2.92B
-5,893
Closed -$373K
MHI
3662
DELISTED
Pioneer Municipal High Income Fund
MHI
-10,203
Closed -$117K
MLN icon
3663
VanEck Long Muni ETF
MLN
$683M
-227,926
Closed -$4.52M
MSTR icon
3664
Strategy Inc
MSTR
$38.4B
-15,760
Closed -$201K
MXL icon
3665
MaxLinear
MXL
$6.8B
-112,605
Closed -$1.76M
NTLA icon
3666
Intellia Therapeutics
NTLA
$1.67B
-8,688
Closed -$238K
ONTO icon
3667
Onto Innovation
ONTO
$15.3B
-7,599
Closed -$269K
OTEX icon
3668
Open Text
OTEX
$6.04B
-28,119
Closed -$990K
OUT icon
3669
Outfront Media
OUT
$5.5B
-23,670
Closed -$453K
PBYI icon
3670
Puma Biotechnology
PBYI
$454M
-7,693
Closed -$455K
PCRX icon
3671
Pacira BioSciences
PCRX
$997M
-21,611
Closed -$693K
PGRE
3672
DELISTED
Paramount Group
PGRE
-146,498
Closed -$2.26M
PICK icon
3673
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.33B
-12,846
Closed -$419K
PLUS icon
3674
ePlus
PLUS
$2.34B
-24,596
Closed -$1.16M
RMCF icon
3675
Rocky Mountain Chocolate Factory
RMCF
$7.84M
-15,504
Closed -$177K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.